So? This has nothing to do with that.
—-what I’m referring to is where in the treatment guidelines or practices this dimx drug will fit because there are a number of immunological drugs already used first line (check this out
https://kdigo.org/wp-content/uploads/2022/12/How-I-Treat-FSGS.pdf
—- this dimx drug looks a comparatively weaker immunological drug compared with the powerful drugs already used, I don’t see it replacing established things referenced in the article like steroids or calcineurim inhib, rituximab.
—— dimx drug looks like it’s v safe, but lack of side effects is probably an indication of its weaker immunological ability.
—-/ looks more like a back up reserve drug to use once you’ve exhausted other things
Ann: Dimerix Completes $20M Placement, page-88
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.005(1.16%) |
Mkt cap ! $239.5M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 44.3¢ | 42.5¢ | $634.3K | 1.458M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9998 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 26920 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |